Improving treatment for gastric cancer in Latino patients using personalized models
Official title: Advancing gastric cancer precision medicine in Latinos through patient-derived modeling
Funded at University of California at Davis · NIH-10896242 · Data updated 2026-11-12
This study is looking at gastric cancer in Latino patients to find specific genetic changes in their tumors that can be targeted with current treatments, hoping to create better and more personalized care for them.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $208,778 |
| NIH project number | 5U54CA283766-02 |
| Project ID | NIH-10896242 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Latino individuals diagnosed with gastric cancer, particularly those with specific genetic mutations.
✕Less likely to help
Patients who do not have gastric cancer or those outside the Latino demographic may not benefit from this research.
What this research studies
This research focuses on understanding gastric cancer, which disproportionately affects Latino populations, by creating patient-derived models that reflect the unique genetic characteristics of their tumors. The approach involves analyzing the molecular subtypes of gastric cancer in Latino patients to identify 'druggable' mutations that can be targeted with existing therapies. By studying the complex genetic alterations in these tumors, the research aims to develop more effective treatment strategies tailored specifically for Latino patients. This could lead to better outcomes and reduced disparities in gastric cancer treatment and survival.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatment options for Latino patients with gastric cancer.
How similar studies have gone: Previous research has shown success in using patient-derived models to identify targeted therapies for various cancers, indicating a promising approach for this study.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
Related research
Other NIH-funded projects on the same topics.
-
Advancing gastric cancer care for Latinos through patient-derived tumor models
Aimed at Latinos with gastric cancer, this project uses patient-derived tumor models to study how cancer biology and treatments work in real tumors.
-
Circulating metabolites as early warning signs for gastric cancer
Researchers will look at blood-based metabolites to find signs that predict gastric cancer risk in people, with a focus on those in large, multi-center cohorts.
-
Understanding why racial differences exist in stomach cancer in the US
This grant studies why some racial groups in the US have higher stomach cancer rates, focusing on how Helicobacter pylori infection and host responses contribute to these differences.
-
Understanding how gastric cancer starts and grows in the stomach
Researchers at Columbia are studying how two main types of stomach cancer begin and progress, using new mouse models and advanced single-cell and spatial analysis to map where cancer cells come from and how they change.
-
Gastric cancer prevention and screening modeled to guide US care
A nationwide modeling project uses AI and advanced simulations to help decide who should be tested and treated for stomach cancer prevention and screening in the United States.
-
Improved fibrin-targeted radiopharmaceutical for gastric cancer
A new radiopharmaceutical targets fibrin in gastric cancer to help treat advanced disease with potentially fewer side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.